# Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants

> **NCT05133830** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 52 (actual)

## Conditions studied

- Pruritus

## Interventions

- **DRUG:** Obeticholic acid
- **DRUG:** Linerixibat

## Key facts

- **NCT ID:** NCT05133830
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-23
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05133830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05133830, "Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05133830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*